article Open AccessTop 1% cited

Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study

The American Journal of Gastroenterology · 2006 · Vol. 101(1) · pp. 139–147

Chi-Liang Cheng(Indiana University – Purdue University Indianapolis)Stuart Sherman✉(Indiana University – Purdue University Indianapolis)James L. Watkins(University of Wisconsin–Madison)Jeffrey L. Barnett(University of Michigan–Ann Arbor)Martin L. Freeman(Hennepin County Medical Center)Joseph E. GeenenMichael Ryan(Marshfield Clinic)Harrison W. ParkerJames T. Frakes(Rockford University)Evan L. Fogel(Indiana University – Purdue University Indianapolis)William B. Silverman(University of Pittsburgh)Kulwinder S. Dua(Indiana University – Purdue University Indianapolis)Giuseppe Aliperti(Indiana University – Purdue University Indianapolis)Paul N. Yakshe(University of Minnesota Children's Hospital)Michael Uzer(Texas Health Dallas)Whitney Jones(University of Louisville)John S. Goff(Indiana University – Purdue University Indianapolis)Laura Lazzell–Pannell(Indiana University – Purdue University Indianapolis)Abdullah Rashdan(Indiana University – Purdue University Indianapolis)M’hamed Temkit(Indiana University – Purdue University Indianapolis)Glen A. Lehman(Indiana University – Purdue University Indianapolis)

View via DOI Publisher page

Abstract

This study emphasizes the role of patient factors (age, SOD, prior history of post-ERCP pancreatitis) and technical factors (number of PD injections, minor papilla sphincterotomy, and operator experience) as the determining high-risk predictors for post-ERCP pancreatitis.

Gallbladder and Bile Duct Disorders Pancreatic and Hepatic Oncology Research Pediatric Hepatobiliary Diseases and TreatmentsMedicineSphincter of Oddi dysfunctionPancreatitisSphincter of OddiInternal medicineOdds ratioIncidence (geometry)Prospective cohort studyUnivariate analysisRisk factor

MeSH terms

AdultAgedAnalysis of VarianceCholangiopancreatography, Endoscopic RetrogradeCommon Bile Duct DiseasesDouble-Blind MethodFemaleFollow-Up StudiesHumansMaleMiddle AgedPancreatitisPrednisonePremedicationPrimary Prevention

Citations

661

FWCI

33.25

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Adverse events associated with ERCP